I am interested in changes in cognitive function (e.g., difficulty concentrating, poorer working memory performance) after a diagnosis of cancer and in biobehavioral correlates of these cognitive changes, particularly genomic markers and co-occurring symptoms. My program of research incorporates several phenotyping approaches to assess changes in cognitive function—including functional and structural neuroimaging, objective neuropsychological tests, and patient-reported outcomes. My current study, funded by the National Institute of Nursing Research (R00NR015473), is using these methods to examine the preliminary efficacy of mindfulness-based stress reduction versus a health enhancement program to improve cognitive function in postmenopausal women receiving aromatase inhibitor therapy for breast cancer.